Table 2 Procedure characteristics of groupPRO, groupREDPRO and groupNOPRO
From: Heparin reversal with protamine sulfate after Percutaneous Hepatic Perfusion (PHP): is less more?
Parameter | GroupPRO | GroupREDPRO | GroupNOPRO |
|---|---|---|---|
Melphalan dose (mg; median (IQR) | 179 (152-203) | 200 (188-212) | 184 (166-201) |
Fluoroscopy time (mm; median (IQR)) | 7 (2-14) | 12 (7-14) | 6 (5-19) |
Intervention time (hh:mm; median (IQR)) | 02:45 (02:28-03:07) | - | 02:00 (01:54-02:15) |
GroupPRO vs NOPRO:p=0.00001 | |||
UFH Dose (I.U.; mean (IQR)) | 41 059 (32 125- 48 815) | 43 775 (37 375- 46 000) | 49 583 (40 000-60 000) |
groupPRO vs REDPRO:p=0.368; groupPRO vs NOPRO:p=0.0006; groupREDPRO vs NOPRO:p=0.156 | |||
Protamine sulfate (I.U.; mean (IQR)) | 34 141 (26 500- 40 000) | 27 368 (20 000- 35 000) | - |
groupPRO vs REDPRO:p=0.036 | |||